Precision Oncology made Easy
Perthera Precision Oncology Platform makes it easy for Oncologists to bring to their patients the full power
of Precision Oncology through ranked therapy options based on their multi-omic molecular profile
Precision oncology made easy
Perthera Precision Oncology Platform makes it easy for Oncologists to bring to their patients the full power
of Precision Oncology through ranked therapy options based on their multi-omic molecular profile
WHY PERTHERA
A patient's story
Lee S., a breast cancer survivor and Oncology Data Specialist, shares why the Perthera Report is so important for cancer patients.
Perthera is leading by delivering a
Precision Oncology platform
Perthera is a pioneer in using multi-omic testing results (DNA, RNA, IHC, and phosphoproteomics) to advise doctors and patients on therapy options through our Precision Oncology Platform. We obtain, or help doctors and patients obtain, multi-omic results from any source and use the power of our Precision Oncology Platform to identify the best treatments available for each patient using our proprietary Ranked Therapy Options process.
The Perthera Ranked Therapy Options, and the Precision Oncology Platform that creates them, have been validated in publications in peer-reviewed, high-impact journals and shown clinically to increase survival rates for those patients who have actionable findings and receive matched therapies. We are determined to make our Precision Oncology Platform the best resource available today for Oncologists in their treatment decision-making process. Perthera’s clients and partners include the Mayo Clinic, Pfizer, AstraZeneca, Novartis, the Department of Defense, and many others.
partner with perthera
do More With Your data
- Review multi-omic testing results for your patients
- Identify local patients for your clinical trials
- Find the best clinical trials for your patients
- Compare real world treatment outcomes across biomarkers
Services
Over 10 years In Precision Oncology
Patients
Physicians
Advocacy
CROs & Labs
Pharma & Drug Development
Payers
The Perthera Report
The Perthera Report is a precision Oncology decision making tool which recommends clinical trials and therapy options based on the specific multi-omic profile of each patient’s cancer. The Perthera report can be updated any time during a patient’s journey with cancer.
Perthera For Physicians
The Perthera Report recommends clinical trials and therapies specific to each patient’s unique situation and multi-omic profile to give physicians the information needed to successfully treat their patients.
Perthera For Physicians
The Perthera Report recommends clinical trials and therapies specific to each patient’s unique situation and multi-omic profile to give physicians the information needed to successfully treat their patients.
Perthera For Patients
Every patient with cancer is unique. Perthera is committed to providing the best ranked therapy options specific to each cancer and patient to give them the best chance of seeing regression and control of their cancer while maintaining quality life.
Perthera For Clinical Partners
Perthera’s Precision Oncology Platform is built to also provide maximum value to our diverse partners such as CROs, testing laboratories, advocacy groups, and payers. We can help them to achieve various goals such as gathering real world evidence, outcomes capture, curation of biomarkers,, clinical trial enrollment, abstraction of structured data for research, and strategies to control treatment costs. We want to partner with anyone who can help us to our goal of providing our help to as many patients with cancer as possible.
Perthera For Clinical Partners
Perthera’s Precision Oncology Platform is built to also provide maximum value to our diverse partners such as CROs, testing laboratories, advocacy groups, and payers. We can help them to achieve various goals such as gathering real world evidence, outcomes capture, curation of biomarkers,, clinical trial enrollment, abstraction of structured data for research, and strategies to control treatment costs. We want to partner with anyone who can help us to our goal of providing our help to as many patients with cancer as possible.
meet the team
Perthera Leadership Team
The Leadership team at Perthera is dedicated to serving our clients and their patients with the best in clinical decision support. We work hard to deliver the best in healthcare innovation and multi-omic insights.
Albert Kelley
president & CEO Board Member
Chip Petricoin
Chief Science Officer
Aurelija Striužė
Director, European Operations
Michael Pishvaian
Chief Medical Officer
TESTIMONIALS
This is why we do what we do
Previous
Next